Image

Developmental Trajectories of Reinforcer Pathology and Childhood Obesity

Developmental Trajectories of Reinforcer Pathology and Childhood Obesity

Recruiting
8-11 years
All
Phase N/A

Powered by AI

Overview

The goal of this observational study is to understand how children's food preferences, physical activity, and decision-making change over time and how these behaviors relate to body weight and overall health.

Description

A cohort sequential design will be used to track 2 cohorts of children aged 8.5-9 years 11 months, and 10.5-11 years 11 months over a 3 year period to understand how the development of food and activity reinforcement and delay discounting could lead to the development of childhood obesity in children aged 9-14.

Eligibility

Inclusion Criteria:

  • Male and female children
  • Black, Indigenous, and People of Color (BIPOC) or Hispanic families
  • Children from low SES families (as defined by household education, eligibility for government assistance)
  • Children in overweight/obese category (defined by range in each cohort)

Exclusion Criteria:

  • Medical causes for obesity
  • Stature below the 5th percentile
  • Physical activity restrictions
  • Psychopathology
  • Medication use that affects activity or appetite
  • Children that spend less than 65% of their time in participating parent's household
  • BMI percentile criteria
  • Liking of study foods and activities
  • Dietary restrictions and food allergies

Study details
    Pediatric Obesity

NCT07229508

State University of New York at Buffalo

1 February 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.